Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Tumor Antigen Identification for Cancer Immunotherapy Publisher



Balibegloo M1, 2 ; Keshavarzfathi M2, 3 ; Rezaei N1, 4, 5
Authors

Source: Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition Published:2020


Abstract

The immune system has shown to be capable of acting against malignant cells, in which recognizing the tumor antigen is an essential step. Tumor antigens are different in structure, expression and presentation, origin, immunogenicity, etc. Thus, it is very important to identify the antigens with favored properties. Several techniques have been developed for tumor antigen identification; the major two categories are indirect immunology based on algorithms predicting the HLA-peptide binding affinity ranking the candidate antigens which will further be validated versus direct HLA peptidomics approach which derives samples, isolates HLA-peptide complex, and determines the sequence of the peptide as a tumor antigen. Better antitumor immunotherapeutics such as personalized medicine, efficient adoptive T-cell therapy, immune vaccines, etc. will be provided through the development of more advanced antigen identification protocols. © Springer Nature Switzerland AG 2015, 2021. All rights reserved.
1. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
2. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
Experts (# of related papers)
Other Related Docs
4. Personalized Cancer Vaccine, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
5. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
6. Personalized Cancer Vaccine, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
7. Immunotherapy of Cancers Comes of Age, Expert Review of Clinical Immunology (2017)
8. Genetically Modified Immune Cells Targeting Tumor Antigens, Pharmacology and Therapeutics (2020)
9. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
10. Tumor Immunology, Clinical Immunology (2022)
11. Biomarkers for Predicting the Outcome of Various Cancer Immunotherapies, Critical Reviews in Oncology/Hematology (2021)
14. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
15. Biomarkers for Immune Checkpoint Inhibitors, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
16. Peptide and Protein Vaccines for Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
20. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)